Fitness in recovery: impact of exercise in people with substance use disorder in residential treatment
Background: Opioid use disorder has the lowest quality of life (QOL) and highest disease burden of all substance use disorders (SUD). While opioid treatment does lead to initial improvements in QOL it remains below that of the general population. The integration of exercise programs as an adjunct therapy for SUD is gaining popularity. Previous reviews have indicated that exercise offers significant benefits for QOL, however the evidence in an opioid treatment population is lacking. This study will investigate the impact of a 12-week exercise intervention on QOL and mood in a residential opioid treatment rehabilitation program.
Methods: This is a 12-week single arm intervention with a natural history control. Participants will complete a baseline screening assessing QOL, mood and exercise habits and those who meet criteria for exercise participation will complete an exercise assessment. The exercise program will be delivered twice per week as part of the group therapy program. Exercise sessions will run for approximately 40 minutes and be at an intensity selected by each of the participants.
Conclusions: A recent review indicated that two sessions of exercise for a minimum of 12 weeks leads to an improvement in QOL in general SUD, however, to date minimal studies have been completed in people receiving opioid agonist treatment. Hence, this will be the first study to our knowledge, assessing the role of exercise as an adjunct treatment for QOL in this population.
Trial Registration: This trial has been registered with the Australian New Zealand clinical trials registry ACTRN12622000213741.
Kresina TF, Lubran R. Improving public health through access to and utilization of medication assisted treatment. Int J Environ Res Public Health. 2011;8(10):4102-17.
Donovan D, Mattson ME, Cisler RA, Longabaugh R, Zweben A. Quality of life as an outcome measure in alcoholism treatment research. J Stud Alcohol Suppl. 2005;(15):119-39.
Aas CF, Vold JH, Skurtveit S, Lim AG, Ruths S, Islam K, Askildsen JE, Løberg EM, Fadnes LT, Johansson KA; INTRO-HCV Study Group. Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway. Subst Abuse Treat Prev Policy. 2020;15(1):68.
Nosyk B, Bray JW, Wittenberg E, Aden B, Eggman AA, Weiss RD, Potter J, Ang A, Hser YI, Ling W, Schackman BR. Short term health-related quality of life improvement during opioid agonist treatment. Drug Alcohol Depend. 2015;157:121-8.
Laudet AB. The case for considering quality of life in addiction research and clinical practice. Addict Sci Clin Pract. 2011;6(1):44-55.
Stenbacka M, Leifman A, Romelsjö A. Mortality and cause of death among 1705 illicit drug users: a 37 year follow up. Drug Alcohol Rev. 2010;29(1):21-7.
Nordentoft M, Wahlbeck K, Hällgren J, Westman J, Osby U, Alinaghizadeh H, Gissler M, Laursen TM. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One. 2013;8(1):e55176.
Dowla R, Murnion B, Hung C, Currell K, Kendig M, Freeston J, & Rooney K. (2021). Exercise capacity and acute effects of exercise on affect in a Substance Use Disorder Population. J Clin Exer Physiol. 2012; 10(4):23-8.
Caviness CM, Bird JL, Anderson BJ, Abrantes AM, Stein MD. Minimum recommended physical activity, and perceived barriers and benefits of exercise in methadone maintained persons. J Subst Abuse Treat. 2013;44(4):457-62.
Dowla R, Sinmaz H, Mavros Y, Murnion B, Cayanan E, Rooney K. The effectiveness of exercise as an adjunct intervention to improve quality of life and mood in substance use disorder: a systematic review. Subst Use Misuse. 2022;57(6):911-28.
Weinstock J, Barry D, Petry NM. Exercise-related activities are associated with positive outcome in contingency management treatment for substance use disorders. Addict Behav. 2008;33(8):1072-5.
Riebe D, Franklin BA, Thompson PD, Garber CE, Whitfield GP, Magal M, Pescatello LS. Updating ACSM's recommendations for exercise preparticipation health screening. Med Sci Sports Exerc. 2015;47(11):2473-9.
Borg G. Psychophysical scaling with applications in physical work and the perception of exertion. Scand J Work Environ Health. 1990;16 Suppl 1:55-8.
Schmidt S, Mühlan H, Power M. The EUROHIS-QOL 8-item index: psychometric results of a cross-cultural field study. Eur J Public Health. 2006;16(4): 420-8.
Testing the reliability and validity of the self-efficacy for exercise scale. Available at: https://oce-ovid-com.ezproxy.library.sydney.edu.au/article/00006199-200005000-00007/PDF. Accessed on 20 August 2022.
Andrews G, Slade T. Interpreting scores on the Kessler Psychological Distress Scale (K10). Aust N Z J Public Health. 2001;25(6):494-7.
Abrantes AM, Battle CL, Strong DR, Ing E, Dubreuil ME, Gordon A, Brown RA. Exercise preferences of patients in substance abuse treatment. Ment Health Phys Act. 2011;4(2):79-87.
Thompson ER. Development and validation of an internationally reliable short-form of the positive and negative affect schedule (PANAS). J Cross-Cultural Psychol. 2007;38(2):227-42.
Dowla R, Murnion B, Roberts K, Freeston J, Rooney K. Physical activity assessment in clinical studies of substance use disorder. Methods Mol Biol. 2018; 1735:273-84.
ACSM’s guidelines for exercise testing and prescription. Available at: ACSM_s_Guidelines_for_ Exercise_Testing_a.html?id=qb6nuAAACAAJ&redir_esc=y. Accessed on 20 October 2021.
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193-213.
Johns MW. Reliability and factor analysis of the Epworth sleepiness scale. Sleep. 1992;15(4):376-81.
Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8): 1381-95.
Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain. 2004;5(2):133-7.